KD

Kanchan Dipak Papdeja

Active Director Director DIN 10790730
DIN 10790730 First appointment Sep 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanchan Dipak Papdeja

Data last updated:

Kanchan Dipak Papdeja is a Director at Yujcell Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10790730
Primary Designation Director
Industry Paper
First Appointment 27 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yujcell Pharma Private Limited U21004MH2024PTC432789
Director27 Sep 20242024Active

Board colleagues of Kanchan Dipak Papdeja

NameDINCompanyDesignation
Kshitij Dipak Papdeja10790729Yujcell Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yujcell Pharma Private Limited
Premium access

Shareholding and investment profile for Kanchan Dipak Papdeja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanchan Dipak Papdeja

Kanchan Dipak Papdeja currently holds 1 directorship: Yujcell Pharma Private Limited (Director, since 27 Sep 2024).

Kanchan Dipak Papdeja was first appointed on 27 Sep 2024 as Director at Yujcell Pharma Private Limited.

The current boards of Kanchan Dipak Papdeja's companies include Kshitij Dipak Papdeja (Yujcell Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available